MCP-1 upregulates amylin expression in murine pancreatic β cells through ERK/JNK-AP1 and NF-κB related signaling pathways independent of CCR2.

Key Laboratory of Nutrition and Metabolism, Institute for Nutritional Sciences, Graduate School of the Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China.
PLoS ONE (Impact Factor: 3.53). 01/2011; 6(5):e19559. DOI: 10.1371/journal.pone.0019559
Source: PubMed

ABSTRACT Amylin is the most abundant component of islet amyloid implicated in the development of type 2 diabetes. Plasma amylin levels are elevated in individuals with obesity and insulin resistance. Monocyte chemoattractant protein-1 (MCP-1, CCL2) is involved in insulin resistance of obesity and type 2 diabetes. We investigated the effect of MCP-1 on amylin expression and the underlying mechanisms with murine pancreatic β-cell line MIN6 and pancreatic islets.
We found that MCP-1 induced amylin expression at transcriptional level and increased proamylin and intermediate forms of amylin at protein level in MIN6 cells and islets. However, MCP-1 had no effect on the expressions of proinsulin 1 and 2, as well as prohormone convertase (PC) 1/3 and PC2, suggesting that MCP-1 specifically induces amylin expression in β-cells. Mechanistic studies showed that although there is no detectable CCR2 mRNA in MIN6 cells and islets, pretreatment of MIN6 cells with pertussis toxin inhibited MCP-1 induced amylin expression, suggesting that alternative Gi-coupled receptor(s) mediates the inductive effect of MCP-1. MCP-1 rapidly induced ERK1/2 and JNK phosphorylation. Inhibitors for MEK1/2 (PD98059), JNK (SP600125) or AP1 (curcumin) significantly inhibited MCP-1-induced amylin mRNA expression. MCP-1 failed to induce amylin expression in pancreatic islets isolated from Fos knockout mice. EMSA showed that JNK and ERK1/2 were involved in MCP-1-induced AP1 activation. These results suggest that MCP-1 induces murine amylin expression through AP1 activation mediated by ERK1/2 or JNK. Further studies showed that treatment of MIN6 cells with NF-κB inhibitor or overexpression of IκBα dominant-negative construct in MIN6 cells significantly inhibited MCP-1-induced amylin expression, suggesting that NF-κB related signaling also participates in MCP-1-induced murine amylin expression.
MCP-1 induces amylin expression through ERK1/2/JNK-AP1 and NF-κB related signaling pathways independent of CCR2. Amylin upregulation by MCP-1 may contribute to elevation of plasma amylin in obesity and insulin resistance.

  • [Show abstract] [Hide abstract]
    ABSTRACT: BALB/c mice inoculated intraperitoneally with coxsackievirus group B type 3 were divided into five different groups including viral myocarditis group infected with CVB3 alone, antibody intervention group with anti-MCP-1, control group of antibody intervention with goat IgG, tMCP-1 intervention group with plasmid pVMt expressing tMCP-1, and control group of tMCP-1 intervention with plasmid pVAX1. Meanwhile the normal control group was designed. The ratio of murine heart weight to body weight, the pathological score of myocardial tissue, the level of creatine kinase-MB fraction in serum and CVB3 loading of myocardial tissue were analyzed. Compared with the mice with viral myocarditis, the cardiac lesion of the mice was alleviated when interfered with 20µg,40µg or 60µg pVMt (P<0.05). Additionally, the number of the infiltrating mononuclear cells in the myocardium with viral myocarditis was decreased when transferred myocardially with 40µg or 60µg pVMt (P<0.01), while there was no difference between the mice with viral myocarditis and the mice interfered with 20µg pVMt (P > 0.05). There was also no difference between the mice interfered with anti-MCP-1 antibody and 40µg pVMt in ratio of HW/BW, the level of CK-MB and PS (P > 0.05). This study demonstrated that tMCP-1 could alleviate the cardiac lesion and cardiac injury of mice with viral myocarditis through intervention with the infiltration of mononuclear cells. Thus, tMCP-1 may be an alternative for the research and therapy of viral myocarditis instead of anti-MCP-1 antibody.
    Microbiology and Immunology 01/2014; · 1.55 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Hyperglycemia induces activation of the c-Jun N-terminal kinase (JNK) pathway, which suppresses insulin gene expression and reduces DNA binding of pancreatic and duodenal homeobox factor (PDX)-1. This study aims to investigate the effects of a novel curcumin derivative (NCD) on JNK signaling pathway on insulin synthesis and secretion in streptozotocin (STZ)-treated rat pancreatic islets in vitro. Isolated rat pancreatic islets were divided into five groups: untreated control group; group treated with NCD (10 muM); group exposed to STZ (5 mM); group treated with NCD (10 muM) and then exposed to STZ (5 mM); and group exposed to STZ (5 mM) and then treated with NCD (10 muM). The pancreatic islets from all groups were used for DNA fragmentation assays and quantitative assessments of the JNK, Pdx1, glucose transporter-2 (GLUT2), heme oxygenase (HO)-1, transcription factor 7-like 2 (TCF7L2), and glucagon-like peptide (GLP)-1 gene expression levels. The intracellular calcium, zinc, and the phosphorylated and total JNK protein levels were assessed. The insulin (secreted/total) and C-peptide levels were examined in islet culture medium. NCD protected pancreatic islets against STZ-induced DNA damage, improved total insulin (P = 0.001), secreted insulin (P = 0.001), and C-peptide levels (P = 0.001), normalized mRNA expressions of insulin, Pdx1, and GLUT2 (P = 0.0001), and significantly elevated calcium and zinc levels (P = 0.0001). All effects were significant when islets were treated with NCD before STZ (P = 0.05). JNK gene overexpression and JNK protein levels induced by STZ were significantly inhibited after NCD treatment of islets ( P = 0.0001). NCD-treated islets showed significantly elevated gene expressions of HO-1, TCF7L2, and GLP-1 (P = 0.0001), and these upregulated gene expressions were more significantly elevated with NCD treatment before STZ than after STZ (P = 0.05). NCD improved insulin synthesis and secretion in vitro in isolated pancreatic islets treated with STZ through inhibition of the JNK pathway, up-regulation of the gene expressions of HO-1, TCF7L2, and GLP-1 and enhancing effects on calcium and zinc levels.
    Chinese Medicine 01/2014; 9(1):3. · 1.79 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: curcumin derivative increases synthesis and secretion of insulin in STZ treated rats
    Chinese Medicine 01/2014; 9:3. · 1.79 Impact Factor

Full-text (2 Sources)

1 Download
Available from